Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Weight Reduction Heterogenicity and Mediators of GLP-1RAs and Dual Agonists for Individuals With Obesity: A Meta-Analysis
Lu D, Li N, Yuan Z, et al.
Clinical obesity;16(5):e70112
GLP-1 receptor agonist use and mental health outcomes in adolescents with obesity: a retrospective review
Said J, Liegl M, Pan AY, et al.
Journal of pediatric endocrinology & metabolism : JPEM, 2026
DUTCH weight control in atrial fibrillation study (DUTCH-WAIST) : Design and rationale of a randomised controlled trial
Voorhout L, Pisters R, Huisman M, et al.
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 2026
Obstructive sleep apnea, GLP-1 receptor agonist pharmacotherapy, and the oral microbiome: competing biological influences and implications for oral health monitoring
Comisi JC
Clinical oral investigations, 2026;30(10)
Effects of GLP-1 receptor agonists on body weight and cardiovascular outcomes: a review
van Maren SJF, van Doorn EPM, Smits MM, et al.
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 2026
Real-World Evidence for Existing Anti-Obesity Therapies-The Realities of Treatment Adherence, Tolerability, Access and Patient Satisfaction
Kassem S
Diabetes, obesity & metabolism, 2026
Potential Associations Between GLP-1 Receptor Agonists and Polyendocrine Metabolic Ovarian Syndrome: Triangulation of Genetic and Pharmacovigilance Evidence
Feng Z, Lian H, Liu C, et al.
Diabetes, obesity & metabolism, 2026
Psychiatric Safety of GLP-1 and Dual GIP/GLP-1 Receptor Agonists in Adolescents With Obesity
Liu TH, Shen YL, Kuo TH, et al.
Diabetes, obesity & metabolism, 2026
Prior GLP-1RA or Tirzepatide Use and Early Cardiorenal Outcomes After Metabolic and Bariatric Surgery
Tseng TC, Chang R
The American journal of medicine, 2026
GLP-1 receptor agonists, epigenetic aging, and the prospect of pharmacological healthspan extension
Al-Ali D, El Hajj N
Experimental gerontology, 2026;:113325
Anaphylaxis to Tirzepatide Confirmed by Positive Skin Prick Testing
Steele C, Crisp H
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2026
Association of GLP-1-based therapy with asthma-related outcomes in patients with obesity: a propensity-matched retrospective cohort study
McCraw CD, Grayeb DR, Gupta N, et al.
Expert review of respiratory medicine, 2026
GLP-1 Receptor Agonists and Musculoskeletal Outcomes: A Systematic Literature Review and Meta-Analysis
Beaudart C, Malréchauffé Y, van Heden S, et al.
Drugs, 2026
Tirzepatide for pasireotide-induced hyperglycemia in a GH/TSH-producing pituitary adenoma/PitNET: a case report and literature review
Iwamoto Y, Yamashita K, Seki Y, et al.
Endocrine journal, 2026
Improvement of small fiber neuropathy assessed by corneal confocal microscopy following semaglutide treatment: a case report and literature review
Anastasiou IA, Tentolouris N, Rebelos E
Hormones (Athens, Greece), 2026
Assessing the Association Between GLP-1 Receptor Agonists and Diabetic Foot Complications Using Real-World Pharmacovigilance Database and Mendelian Randomization
Zhang T, Luo X, Chen C, et al.
The international journal of lower extremity wounds, 2026;:15347346261487722
International expert panel review for the use of resmetirom and semaglutide in the management of MASH-related fibrosis: clinical practice update
Mironova M, Ratziu V, Rinella ME, et al.
Gut, 2026
Structural Overview of GLP-1 Analogs
van der Velden WJC, Andresen AF, Rosenkilde MM
Biomedical journal, 2026;:101037
Where the Future Lies: GLP-1 Receptor Agonists as Therapeutics for Dermatologic Comorbidities
DeCoster M, Narla S
Clinics in dermatology, 2026
Metabolic Effects of a GLP-1 Analog Combined with Aerobic Training in Ovariectomized Rats
Selau B, Bastos LM, Normann RS, et al.
Molecular and cellular endocrinology, 2026;:112917